Correlation Between EnGene Holdings and Beam Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EnGene Holdings and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnGene Holdings and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between enGene Holdings Common and Beam Therapeutics, you can compare the effects of market volatilities on EnGene Holdings and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnGene Holdings with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnGene Holdings and Beam Therapeutics.

Diversification Opportunities for EnGene Holdings and Beam Therapeutics

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between EnGene and Beam is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding enGene Holdings Common and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and EnGene Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enGene Holdings Common are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of EnGene Holdings i.e., EnGene Holdings and Beam Therapeutics go up and down completely randomly.

Pair Corralation between EnGene Holdings and Beam Therapeutics

Given the investment horizon of 90 days enGene Holdings Common is expected to generate 0.87 times more return on investment than Beam Therapeutics. However, enGene Holdings Common is 1.15 times less risky than Beam Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Beam Therapeutics is currently generating about 0.07 per unit of risk. If you would invest  660.00  in enGene Holdings Common on August 30, 2024 and sell it today you would earn a total of  208.00  from holding enGene Holdings Common or generate 31.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

enGene Holdings Common  vs.  Beam Therapeutics

 Performance 
       Timeline  
enGene Holdings Common 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.
Beam Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

EnGene Holdings and Beam Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EnGene Holdings and Beam Therapeutics

The main advantage of trading using opposite EnGene Holdings and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnGene Holdings position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.
The idea behind enGene Holdings Common and Beam Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope